Trial record 2 of 3 for:    Interleukin-2 in Metastatic Melanoma quan

Low-dose Cyclophosphamide and Outpatient IV Interleukin-2 in Metastatic Melanoma

This study has been withdrawn prior to enrollment.
(No participants enrolled)
Sponsor:
Information provided by (Responsible Party):
Walter Quan Jr., MD, Western Regional Medical Center
ClinicalTrials.gov Identifier:
NCT01833767
First received: April 14, 2013
Last updated: June 1, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)